Genetic Research: Selfish DNA versus Vector-Borne Disease by Hood, Ernie
We have to choose between a global market driven only by calculations of 
short-term profit, and one which has a human face.
Kofi Annan, address to World Economic Forum, 31 January 1999
Environews Forum
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Does City Life Alter
Breast Density?
Epidemiologic studies have found differ-
ences between urban and rural women in
breast cancer incidence and mortality, both
generally being higher in urban areas. Now a
British study suggests that women who live
or work in urban areas have denser breasts
and thus potentially a greater risk of breast
cancer, according to a report published
online 19 December 2007 ahead of print in
Current Medical Research and Opinion. The
new findings add to the evidence that breast
cancer risk is higher in urban settings and
may eventuate in new breast cancer screen-
ing guidelines. 
Breasts are made up of glandular and
fatty tissue. Glandular tissue is denser than
fatty tissue and harder to read on a mammo-
gram; a higher percentage of dense tissue is
also linked with increased risk of breast can-
cer. A meta-analysis of more than 40 studies
published in the June 2006 issue of Cancer
Epidemiology, Biomarkers & Prevention
concluded that women with high breast
density have a nearly 5-fold higher breast
cancer risk than women with the lowest
breast density.
The researchers analyzed digital mam-
mograms of 972 women, including 318
women from London and 654 women from
outside the capital. All the women had
received mammography at The Princess
Grace Hospital in London. The researchers
found that women aged 45–54 who lived in
central London were twice as likely to have
very dense breasts as women who lived in
outlying suburban and rural areas. Age-spe-
cific analyses indicated that breast density
differences by area were more pronounced in
women under age 50.
Study leader Nicholas M. Perry, director
of the London Breast Institute at The
Princess Grace Hospital, was not particular-
ly surprised by the study’s findings. While
working as a radiologist over a 15-year peri-
od, Perry had observed that London women
tended to have denser breasts than women
living in outlying areas. These personal
observations were the main impetus for the
study. “Our study was not designed to do
anything other than report on the original
observation that urban women seemed to
have denser breasts,” he says. “Since releasing
our findings, I have received numerous com-
ments from radiologists who have observed
the same phenomenon.”
The biological basis for the new finding
remains to be determined. “It may simply be
that London women are thinner than
women living outside the capital, or it may
be due to other factors,” says coauthor
Stephen Duffy, an epidemiologist at Cancer
Research UK and Queen Mary, University
of London. “We need to carry out research
on density and other breast cancer risk fac-
tors at the individual level by area of resi-
dence to get to the bottom of this.”
Although mammographic density is a
strong risk factor for breast cancer, it is not
the only one. As an observational study, the
London study did not control for factors
such as suboptimal body weight, which also
can influence density and is an independent
risk factor for breast cancer. 
“Before it can be concluded that urban
or rural residence influences mammographic
density, it must be shown that the individu-
als living in urban or rural environments do
not differ in one or more factors that influ-
ence density,” says Norman Boyd, a senior
scientist at the Campbell Family Institute for
Breast Cancer Research at Princess Margaret
Hospital in Toronto. “Body weight is a
strong influence on density, and it is known
that obesity is more common in rural than in
urban settings, and that obesity is less com-
mon among professionals than in those with
other occupations. Both of these factors
could explain the observed findings. If those
in rural settings also had more children, that
could also contribute.” Boyd’s research team
is presently focused on identifying the genet-
ic and environmental factors that influence
mammographic density and the relationship
of these factors to breast cancer risk.
Perry’s team speculates that their obser-
vations can be at least partially attributed to
environmental factors such as estrogenic par-
ticles present in traffic emissions. They pres-
ent this argument in a letter to the editor
published online 8 December 2007 ahead of
print in Cancer Causes & Control. Still, Perry
cautions that more research is needed to
determine the underlying reasons for this
phenomenon, taking into account stress as
well as lifestyle and environmental factors.
“We intend to carry on with this research in
the form of an intervention trial and hope
other groups will do the same,” he says.
“There is also likely to be a consensus confer-
ence before long addressing the issue of
breast density and how it is modulated.” 
In the interim, he urges urban women
to be especially vigilant about breast cancer
screening and to rely primarily on digital
mammography, which is more effective
than conventional mammography at
detecting cancer in dense breast tissue. At
the present time, only about 25% of cen-
ters in the United States and 10% of mam-
mography centers in England offer digital
mammography. –M. Nathaniel Mead
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WOMEN’S HEALTH
Population density? Observational data suggest city women have denser breast tissue than women in out-
lying areas, but the reason for the difference is unclear (inset, l–r: less dense and more dense breast tissue). Transportation
Fuels on the Table
On 29–30 November 2007, just days before
the United Nations Climate Change
Conference began in Bali and Al Gore and
Rajendra Pachauri received the 2007 Nobel
Peace Prize for their work on climate change,
the U.S. Institute of Medicine (IOM) held a
workshop to highlight
gaps in scientific under-
standing about the
environmental and
human health effects of
transportation fuels.
The transportation
sector’s use of fuel is
expected to grow more
quickly than demand
for energy in any other
sector between 2005
and 2030, Scott
Nauman, manager of
economy and energy
in the ExxonMobil
Corporate Planning
Department, told con-
ference attendees. Therefore, new trans-
portation fuels are key players among the
innovative technologies being investigated
and developed to help countries throughout
the world cut greenhouse gas emissions.
As worldwide transportation fuel use
rises, the emissions and carbon dioxide
emitted by burning these fuels will also
rise, pointed out Samuel Wilson, acting
director of the NIEHS. “We want to add
‘minimizing the human health impact’ . . .
to the criteria for developing alternative
fuels,” he said. 
According to Michael Wang, a vehicle
and fuel systems analyst at the U.S. Depart-
ment of Energy Argonne National Labo-
ratory, biofuels are considered the most
promising alternative for reducing petrole-
um use and decreasing greenhouse gas emis-
sions from transportation. Electricity is also
expected to grow as a source for plug-in
hybrids, as is hydrogen. The idea of produc-
ing transportation fuels from coals “has gen-
erated some interest lately because they can
be produced domestically,” Wang says, but
their carbon emissions are “pretty high.”
The main biofuel currently being devel-
oped for transportation in the United States
is ethanol from corn via distillation, and its
production is increasing rapidly. According
to the Energy Information Administration,
the percentage of the U.S. gasoline pool rep-
resented by ethanol rose from 1.27% in
2000 to 2.85% in 2005. However, John
Regalbuto, director of the National Science
Foundation’s Catalysis and Biocatalysis
Program, predicts that hydrocarbon-based
“green gasoline,” “green diesel,” and “green
jet fuel” will represent a significant fraction
of new biofuels by 2022. When produced
via catalysis from materials such as switch-
grass and waste wood products, the per-
formance of these renewable biofuels are
“essentially the same” as their conventional
counterparts, he says. However, their
manufacture involves
intermediates such as
hydroxymethylfurfural
and ionic liquid sol-
vents that require fur-
ther study in terms of
health effects.
Additives also affect
the emissions of trans-
portation fuels, as well
as these fuels’ impact
on the environment,
stressed Serap Erdal, an
assistant professor at
the University of Illinois–
Chicago School of
Public Health. Uncer-
tainty over which addi-
tives will be added to new fuels and how the
complex mixtures will behave in the envi-
ronment makes it very hard to predict
potential health effects, agreed the experts
amassed at the IOM meeting. In the United
States, for example, ethanol has only recent-
ly been used as an additive to make gasoline
burn more efficiently. But in Brazil, where
ethanol has been used as a fuel for nearly 30
years, it has become clear that, compared
with gasoline, the sugarcane-derived fuel
produces much higher emissions of form-
aldehyde, a known human carcinogen, and
acetylaldehyde, a suspected human carcino-
gen, said Paolo Saldiva, a professor of medi-
cine in the University of São Paolo’s Depart-
ment of Pathology. However, he said that
the health effects of exposure to these com-
pounds via air emissions are unclear. 
What is indisputable is that key deci-
sions leading to the development of new
fuels will be made before the requisite health
effects data are available, so “we need to get
going as soon as possible . . . to collect base-
line data,” said Dan Greenbaum, president
of the Health Effects Institute, which pub-
lished a report summarizing the health
effects of exposure to 21 mobile source air
toxics in November 2007. Added Erdal,
“There is a critical need to institute public
health surveillance so that we are already col-
lecting data and are able to detect changes as
they take place.” –Kellyn S. Betts
Antibacterial Alters Hormone
Activity
In a study published online 29 November 2007 ahead
of print in Endocrinology, researchers at the
University of
California, Davis,
report that the
commonly used
antibacterial chemical
triclocarban (TCC) acts
as an endocrine
disruptor by a
previously unreported
mechanism. In human
cells, the researchers
found that TCC
increased gene expression that is normally regulated
by testosterone. In male rats, they found that
testosterone-dependent organs grew abnormally
large after the rats were fed TCC. Until this study,
endocrine disruptors had only been found to block
the effects of hormones. TCC has been used in a
variety of household and personal care products for
more than 45 years.
Raising Awareness of Nurse
Health
On 11 December 2007, the Environmental Working
Group released the results of a survey of
occupational health among nurses. More than 1,500
U.S. nurses participated in the online survey, which
assessed workplace exposures to common hazardous
substances and other agents as well as the health of
nurses’ children. As had been seen in earlier studies,
nurses who experienced routine high exposures to
sterilizing and cleaning chemicals, residues from
drug preparation, anesthetic gases, radiation, and
other hazardous agents reported higher rates of
asthma, miscarriage, and certain cancers, and their
children had higher rates of cancer and birth defects
(especially musculoskeletal defects). The goal of the
survey was to encourage hospitals to minimize risks
to nurses and inspire further study.  
Minnesota Bans Mercury in
Beauty Products
On 1 January 2008, Minnesota became the first state
to ban mercury from cosmetics such as mascara,
eyeliner, and skin-
lightening creams.
Current federal
regulations allow up to
65 ppm mercury to be
used in cosmetics as a
preservative and
germicide. The cosmetics
industry claims the levels
of mercury found in
cosmetics pose little risk
to human health, but an
August 2005 WHO
policy paper asserts that
“studies suggest that
mercury may have no threshold below which some
adverse health effects do not occur.” Skin-lightening
creams could pose more of a health risk as people
generally apply relatively large amounts of them
over sizeable areas of their bodies.
Forum
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INNOVATIVE TECHNOLOGIESStress Link Redefined
As the battle against cancer continues, doctors, researchers, and
patients continue to investigate new avenues for prevention and
treatment. But the struggle isn’t getting any simpler. Researchers in
a handful of laboratories have recently documented that, among
many other triggers and promoters, stress hormones are a direct
contributing factor in the progression of ovarian and nasopharyn-
geal cancer. Now a team from The Ohio State University has dis-
covered a similar link with a third cancer, multiple myeloma. 
Multiple myeloma, which involves lymphoid tumors, kills
more than 10,000 Americans annually, usually within 3 to 4 years
of diagnosis. Ovarian and nasopharyngeal cancers are characterized
by solid epithelial tumors and result in about 15,000 and 650 U.S.
deaths per year, respectively. 
Until recently, stress hormones were thought to simply weaken
the immune system and impair the body’s ability to fight cancer.
Instead, the new evidence is showing that stress hormones such as
norepinephrine, epinephrine, and cortisol, whether induced by
psychological stimuli or environmental agents such as cold temper-
atures or infectious diseases, may play a much different role in can-
cer progression than generally presumed. 
The Ohio State researchers began their study, published online
5 November 2007 ahead of print in Brain, Behavior, and
Immunity, with a few givens: multiple myeloma has been linked
with increased growth of supporting blood vessels, and vascular
endothelial growth factor (VEGF) has been shown to play a role in
that vessel growth. The team evaluated 3 human cell lines from 3
patients, representing different stages of multiple myeloma, to see
if either of 2 doses of norepinephrine played a role in the expres-
sion of VEGF in the cell lines.
Based on their assessment of selected adrenergic receptors in
the cell lines, they found that norepinephrine stimulated all 3 cell
lines. The FLAM-76 cell line taken from bone marrow, which
represented the earliest stage of multiple myeloma, showed the
most significant stimulation. 
Responses in all 3 cell lines were dose- and time-dependent, but
there were no distinct patterns. Depending on the circumstances,
either the higher or lower dose induced the most stimulation or
suppression, and there were large differences over 1-, 3-, 6-, and 24-
hour periods. 
Eric Yang, lead author of the study and a research scientist at
The Ohio State University Institute for Behavioral Medicine
Research, points out that the effect on multiple myeloma of chron-
ic stress from single or multiple sources is unknown. In addition, he
says that the lowest concentration of norepinephrine tested was 10
times higher than levels typically detected in stressed humans.
However, he says the team’s attempts to test at more realistic con-
centrations were stymied by erratic results that were difficult to
interpret. But analogous research on ovarian cancer has shown sim-
ilar effects at realistic doses.
Anil Sood, a professor of gynecologic oncology and cancer
biology at the University of Texas M.D. Anderson Cancer Center,
says that for stress and cancer the effects of other variables such as
age, sex, race, ethnicity, and genetic makeup also remain a puzzle,
and that there is little information on how best to manage or treat
chronic stress in order to reduce its potential effects on tumor
growth. Another concern is that the cell lines were grown in a tis-
sue culture that can’t represent what actually occurs in the body,
says Bruce Rabin, a professor of pathology, psychiatry, and psy-
chology at the University of Pittsburgh School of Medicine.
However, Rabin says the evidence from the experiments is a good
first indication of possible effects of stress hormones on multiple
myeloma. –Bob Weinhold
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Selfish DNA versus
Vector-Borne
Disease
Malaria, carried by Anopheles mosquitoes,
infects up to 500 million people each year
and kills 1 million, most of them children in
sub-Saharan Africa. Dengue fever, a viral dis-
ease transmitted by Aedes mosquitoes, is now
endemic in more than 100 countries and
strikes an estimated 50 million people per
year. Major international efforts to control,
prevent, or eradicate these diseases are in
place, but traditional methods such as vac-
cines and insecticides have met with limited
success. Now scientists are exploring the use
of so-called selfish DNA to bioengineer mos-
quitoes that will take over vector populations,
eventually suppressing the diseases altogether.
Selfish DNA is defined as a segment of
the genome with no apparent function other
than to ensure its own replication. Such ele-
ments—which include transposons and
homing endonuclease genes—are unique in
that they can replicate themselves within a
genome and are not necessary for the repro-
ductive success (or “fitness,” in evolutionary
terms) of the host organism. Selfish genes
may be the ideal vehicles to deliver knockout
blows to vector-borne diseases.
“You can do this in two ways,” says Fred
Gould, a professor of entomology at North
Carolina State University. “One is to have the
selfish DNA element be neutral—that is, it
just inserts itself into the population and
doesn’t actually lower the fitness of the organ-
ism, but it carries with it . . . an antipathogen
gene. So you wind up with a population that
looks the same and has the same fitness, but
can’t transmit the disease. The other
approach is to actually have these selfish
genes drive through a [vector] population
and decrease its fitness, so that their density
goes down.”
Some of these methods have shown suc-
cess in the laboratory, but they are all still
many years away from field deployment.
Hoping to accelerate that process, Gould
and 2 colleagues organized a conference
held 5–7 December 2007 at the National
Evolutionary Synthesis Center (NESCent)
in Durham, North Carolina. Part of
NESCent’s mission is to host “catalysis
meetings”—intensive interactive sessions
that bring together diverse groups to spark
CANCER
GENETIC RESEARCH
Mosquito larvae to be tested for malaria, KenyaEnvironmental Health Perspectives • VOLUME 116 | NUMBER 2 | February 2008 A 69
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Hops for Health?
Xanthohumol, a flavonoid compound found in the
hop plant, is a powerful antioxidant that can reduce
the activity of cancer-causing cytochrome P450
enzymes. Earlier studies have found that
xanthohumol can kill
cultured breast, colon,
ovarian, and prostate
cancer cells, and can
also reduce the
oxidation of LDL
(“bad”) cholesterol.
Now an article in the
November 2007 issue
of Apoptosis shows
that xanthohumol
induces apoptosis in
adipocytes and inhibits
adipogenesis in
maturing preadipocytes, leading its authors to
conclude the compound could be useful as an
antiobesity agent. Also in autumn 2007, the
German company TA-XAN AG launched XAN
Wellness, the first product to employ a patented
process that supposedly boosts the health-
promoting properties of xanthohumol.  
New Tactic for Taming
Invasive Species
Each year, in response to rules adopted in 2004 by
the International Maritime Organisation (IMO), the
shipping industry spends billions of dollars to
remove exotic species from the 3–5 billion tons of
water transported in ballast tanks. A South African
company, Resource Ballast Technologies, is on track
to commercialize a new system for this purpose
that, unlike some conventional methods, does not
use harmful chemicals. Instead, it combines ozone
and ultrasonic radiation to kill organisms. The small
unit fits on existing ballast discharge pipes. The
company has submitted its technology to the IMO
for approval.
Germany Takes Aim at Auto
Emissions
On 1 January 2008, the German cities of Berlin,
Cologne, and Hanover witnessed the rollout of a
new program to reduce air pollution in city centers.
In those cities, and in 17
more to be added
during the year, cars are
required to display
color-coded stickers that
reflect how much fine
particulate pollution
they emit, as
determined by an
authorized testing
facility. Cars that emit
too much particulate
matter will not be
allowed in central
“environmental zones,”
or umweltzones, of participating cities. Drivers who
enter city centers without a sticker will receive a fine
of up to US$60 dollars and a point on their driver’s
license. The new laws are part of an effort to help
Germany meet new European Union standards for
air quality.
Consumer Action Guide to 
Toxic Chemicals in Toys ehpnet
On 5 December 2007, the nonprofit Ecology Center launched the Consumer
Action Guide to Toxic Chemicals in Toys at http://www.healthytoys.org/ to
provide parents and other caregivers with information on toys containing
potentially hazardous chemicals such as lead, arsenic, and mercury. The site
currently contains basic screening information on more than 1,200 toys that
were tested using X-ray fluorescence to determine amount of various chemi-
cals on a toy’s surface. Each toy receives an overall rating as well as separate
ratings for 5 chemicals—lead, chromium, chlorine/PVC, arsenic, and mercury.
The ratings are not intended to measure health risk or actual user exposure.
The Product Action Guide lists toys by manufacturer and type and by best
and worst rated; visitors can also search by specific toy name. Each toy’s page
lists its ratings as well as an overview of which parts of the toy were tested,
and the amounts of the chemicals of concern detected. Also noted is the pres-
ence of other potentially toxic chemicals such as tin, antimony, chromium, and
bromine if levels above 100 ppm were found (these chemicals are not, how-
ever, used in calculating the overall rating for items). 
The Buy Toys Safely page under the Take Action subhead offers advice
for buying safer toys. The site also has a list of frequently asked questions
that includes topics ranging from lead paint in homes to how to find out
about product recalls. In the Chemicals of Concern section, visitors can learn
about the chemicals tested, alternatives to these chemicals, and other
resources for information on healthy products, toy safety, and ecolabeling
programs in the United States and abroad. Visitors can also use the Test My
Toy! feature to nominate additional toys for testing. In the site’s first 2
weeks, more than 4,500 additional toys were nominated, of which 22 were
tested. –Erin E. Dooley 
new ideas and new collaborations in
emerging fields. 
“Selfish DNA and the Genetic Control
of Vector-Borne Diseases” gathered approxi-
mately 30 researchers whose work ranges
from basic to applied science, and whose
focus ranges from the molecular to the pop-
ulation level. “Having people with really spe-
cific expertise in the basic sciences talking to
people who are trying to apply these things
gave good insights,” says Gould. “There was
a deep interdisciplinary interaction, and it
wasn’t just superficial or lip service.” 
Participants discussed some of the enor-
mous challenges that remain to be overcome
before any of these strategies will be ready for
large-scale deployment. Among these are per-
fecting the models and determining the opti-
mal combination of gene drive systems (i.e.,
methods of effectively introducing the desired
gene into the population) and effector genes
(which encode the antipathogenic element)
to maximize vector control and minimize the
development of resistance by the pathogens. 
So when might we realistically expect to
see mosquitoes modified with selfish DNA
deployed in the field? “We’ve been saying ten
years for the last ten years,” says Anthony
James, a professor of microbiology and
molecular genetics at the University of
California, Irvine, and principal investigator
for a large, multicenter research project into
several of the applications being developed
for genetic control of dengue virus transmis-
sion. “It’s such an adjustable horizon because
as we get closer to something actually work-
ing, the size and scope of the challenges actu-
ally change.” The risk, says Gould, is that a
prematurely deployed system would fail to
control the disease, resulting in a rebound
effect by resistant disease strains and perhaps
permanently closing the window on all
genetic control strategies. 
Another question is whether the public
can—or indeed should—accept the idea of
releasing genetically modified organisms
into the environment, let alone insects that
are encouraged to spread, invade, and super-
sede native populations. Says Gould, “I
think it’s important to stress that there are a
million children a year dying of malaria, and
preventing that is a much bigger benefit
than the risk of a single gene moving into
another Anopheles species—the risks of genes
moving and disrupting habitats are small.”
–Ernie Hood